Live: Will Palantir Beat Q1 Earnings Tonight After Market Close?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Aug 27, 2018 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest in most of the…

Paul Ausick | Aug 24, 2018 at 1:15 PM EDT

The Safest Level of Drinking Alcohol: None

Results of a new study on the effects of alcohol use conclude that the safest level of drinking is none.…

Chris Lange | Aug 23, 2018 at 3:17 PM EDT

Kala Pharma Sees Unexpected Reaction to FDA Approval

Kala Pharmaceuticals shares dipped on Thursday after the U.S. Food and Drug Administration (FDA) announced that it had approved INVELTYS…

Chris Lange | Aug 22, 2018 at 12:35 PM EDT

Valeritas Gears Up For Secondary Offering

Diabetes-focused medtech company Valeritas has filed with the SEC regarding its initial public offering.

Trey Thoelcke | Aug 22, 2018 at 12:30 PM EDT

7 Biotech Stocks Insiders Are Loading Up On

La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Chris Lange | Aug 21, 2018 at 1:05 PM EDT

How the FDA Is Fighting the Nationwide EpiPen Shortage

The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school…

Chris Lange | Aug 21, 2018 at 11:45 AM EDT

Why Premier Is Tuesday’s Big Earnings Winner

Premier shares soared after it reported its fiscal fourth-quarter results before the markets opened on Tuesday.

Chris Lange | Aug 20, 2018 at 10:35 AM EDT

Why Amneal Is Monday’s Big Biopharma Winner

Amneal Pharma shares hit a post-IPO high in Monday’s session after the company announced a new licensing and supply agreement.

Jon C. Ogg | Aug 18, 2018 at 10:00 AM EDT

5 Speculative Biotech Analyst Picks With Upside Targets of 100% to 400%

24/7 Wall St. has identified several biotech analyst calls from Wall Street wherein the analysts are projecting upside of 100%…

Chris Lange | Aug 16, 2018 at 1:55 PM EDT

Are Teva and Mylan Entering an EpiPen Price War to Zero?

Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva…

Chris Lange | Aug 16, 2018 at 12:55 PM EDT

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Teva and Regeneron both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial…

Chris Lange | Aug 16, 2018 at 11:15 AM EDT

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

Vertex Pharmaceuticals shares saw a handy gain on Thursday after the FDA gave a nod to Vertex’s cystic fibrosis treatment.

Chris Lange | Aug 16, 2018 at 9:55 AM EDT

Why Summit Therapeutics Is One of Thursday’s Top Biotechs

Summit Therapeutics shares made a solid gain early on Thursday after the firm announced that it was awarded an additional…

1 … 122 123 124 125 126 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Short Sellers Run for Cover From Major Biotechs

The Safest Level of Drinking Alcohol: None

Kala Pharma Sees Unexpected Reaction to FDA Approval

Valeritas Gears Up For Secondary Offering

7 Biotech Stocks Insiders Are Loading Up On

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

How the FDA Is Fighting the Nationwide EpiPen Shortage

Why Premier Is Tuesday’s Big Earnings Winner

Why Amneal Is Monday’s Big Biopharma Winner

5 Speculative Biotech Analyst Picks With Upside Targets of 100% to 400%

Are Teva and Mylan Entering an EpiPen Price War to Zero?

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

Why Summit Therapeutics Is One of Thursday’s Top Biotechs

Live: Will Palantir Beat Q1 Earnings Tonight After Market Close?

Live: onsemi Q1 Earnings Tonight. Can the Stock Continue Its 90% YTD Rally?

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

KLA Is Gaining Share as AI Chip Complexity Drives Up Yield Costs

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Short Sellers Run for Cover From Major Biotechs

The Safest Level of Drinking Alcohol: None

Kala Pharma Sees Unexpected Reaction to FDA Approval

Valeritas Gears Up For Secondary Offering

7 Biotech Stocks Insiders Are Loading Up On

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

How the FDA Is Fighting the Nationwide EpiPen Shortage

Why Premier Is Tuesday’s Big Earnings Winner

Why Amneal Is Monday’s Big Biopharma Winner

5 Speculative Biotech Analyst Picks With Upside Targets of 100% to 400%

Are Teva and Mylan Entering an EpiPen Price War to Zero?

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

Why Summit Therapeutics Is One of Thursday’s Top Biotechs

Live: Will Palantir Beat Q1 Earnings Tonight After Market Close?

Live: onsemi Q1 Earnings Tonight. Can the Stock Continue Its 90% YTD Rally?

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

KLA Is Gaining Share as AI Chip Complexity Drives Up Yield Costs

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how